-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Ibere Pharmaceuticals quarterly/annual Nonoperating Income (Expense) history and growth rate for 2021.
- Ibere Pharmaceuticals Nonoperating Income (Expense) for the quarter ending September 30, 2022 was $1.02M, a 50% decline year-over-year.
- Ibere Pharmaceuticals Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was $7.22M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)